# Gdańsk Medical University
**Type:** Institutions
**Canonical URL:** https://scholariq.org/institutions/gdansk-medical-university/
## Facts
| Field | Value |
| --- | --- |
| Avg h-index | 45 |
| Citations | 1,306,969 |
| City | Gdansk |
| Country | PL |
| Description | Gdańsk Medical University is a research organisation in Gdansk, PL. OpenAlex records 28,498 works and 1,306,969 citations for it. 6,469 researchers list it as their most recent affiliation. |
| Homepage | http://mug.edu.pl/ |
| OpenAlex ID | https://openalex.org/I75124487 |
| Researchers | 6,469 |
| ROR ID | https://ror.org/019sbgd69 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q5529378 |
| Works | 28,498 |
## University papers
Showing 12 of 42.
- [A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer](https://scholariq.org/papers/a-randomized-trial-of-exemestane-after-two-to-three-years-of-tamoxifen-therapy/)
- [Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC](https://scholariq.org/papers/atezolizumab-for-first-line-treatment-of-pd-l1-selected-patients-with-nsclc/)
- [Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer](https://scholariq.org/papers/adjuvant-olaparib-for-patients-with-i-brca1-i-or-i-brca2-i-mutated-breast-cancer/)
- [Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document](https://scholariq.org/papers/reappraisal-of-european-guidelines-on-hypertension-management-a-european-society-2/)
- [5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)](https://scholariq.org/papers/5th-eso-esmo-international-consensus-guidelines-for-advanced-breast-cancer-abc-5/)
- [4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)](https://scholariq.org/papers/4th-eso-esmo-international-consensus-guidelines-for-advanced-breast-cancer-abc-4/)
- [Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial](https://scholariq.org/papers/survival-and-safety-of-exemestane-versus-tamoxifen-after-2-3-years-tamoxifen/)
- [Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document](https://scholariq.org/papers/reappraisal-of-european-guidelines-on-hypertension-management-a-european-society/)
- [Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer](https://scholariq.org/papers/final-results-from-prime-randomized-phase-iii-study-of-panitumumab-with-folfox4/)
- [A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo](https://scholariq.org/papers/a-dll3-targeted-antibody-drug-conjugate-eradicates-high-grade-pulmonary/)
- [Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/efficacy-of-the-mage-a3-cancer-immunotherapeutic-as-adjuvant-therapy-in-patients/)
- [Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer](https://scholariq.org/papers/phase-iii-trial-of-ipilimumab-combined-with-paclitaxel-and-carboplatin-in/)
## University researchers
- [Leszek Tylicki](https://scholariq.org/researchers/leszek-tylicki/)
- [Przemysław Rutkowski](https://scholariq.org/researchers/przemys-aw-rutkowski/)
- [Zbigniew Heleniak](https://scholariq.org/researchers/zbigniew-heleniak/)
## University top topics
Showing 8 of 25.
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Analytical Chemistry and Chromatography](https://scholariq.org/topics/analytical-chemistry-and-chromatography/)
- [Nutrition and Health Studies](https://scholariq.org/topics/nutrition-and-health-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Heart Rate Variability and Autonomic Control](https://scholariq.org/topics/heart-rate-variability-and-autonomic-control/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.